A preliminary clinical study has demonstrated that the experimental drug tofersen may be effective in the treatment of a genetic form of ALS.
Browsing: Amyotrophic lateral sclerosis
Researchers have demonstrated that there may be a link between playing professional soccer and developing ALS. Soccer players studied were almost twice as likely to develop the disease than the general population.
Gene therapy for disorders such as amyotrophic lateral sclerosis, Parkinson’s disease and Batten disease has seen success in animal models.
Researchers have revealed that RNA-binding proteins accumulate in the brains of people with non-heritable amyotrophic lateral sclerosis and frontotemporal dementia.
A potential new therapeutic for inherited amyotrophic lateral sclerosis, which extended survival and reversed fatal neuromuscular damage in rodents, has entered Phase I/II clinical trials.
After careful evaluation of the ‘Right to Try ‘Act, BrainStorm have announced that it will not make NurOwn® available under this legislation at this time.
Researchers have identified genes in the human genome that could modify the severity of amyotrophic lateral sclerosis and frontotemporal dementia.
Disturbance to nuclear transport caused by protein aggregation has been implicated in the pathology of ALS and FTD.
As we begin a new year on Neuro Central, we’re taking this opportunity to look back at some of the highlights across neuroscience and neurology in 2017.
Discover more about how advances in amyotrophic lateral sclerosis research are influencing approaches to patient care in this review from Neurodegenerative Disease Management